JOURNEY MEDICAL CORPORATION - COMMON STOCK

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

12 Nov 2024 16:01:12 By Nasdaq GlobeNewswire

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

04 Nov 2024 07:00:53 By Nasdaq GlobeNewswire

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

25 Oct 2024 08:30:35 By Nasdaq GlobeNewswire

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

03 Oct 2024 08:30:23 By Nasdaq GlobeNewswire

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

09 Sep 2024 08:30:35 By Nasdaq GlobeNewswire

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

04 Sep 2024 08:15:03 By Nasdaq GlobeNewswire

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

12 Aug 2024 16:01:35 By Nasdaq GlobeNewswire

Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024

06 Aug 2024 16:01:38 By Nasdaq GlobeNewswire

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors

11 Jul 2024 16:05:39 By Nasdaq GlobeNewswire

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

15 May 2024 16:01:52 By Nasdaq GlobeNewswire

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

13 May 2024 16:01:47 By Nasdaq GlobeNewswire

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

07 May 2024 08:30:10 By Nasdaq GlobeNewswire

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer

01 May 2024 16:01:30 By Nasdaq GlobeNewswire

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

25 Apr 2024 08:30:48 By Nasdaq GlobeNewswire

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

21 Mar 2024 16:01:27 By Nasdaq GlobeNewswire

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

18 Mar 2024 08:30:30 By Nasdaq GlobeNewswire

Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024

15 Mar 2024 08:30:01 By Nasdaq GlobeNewswire

Journey Medical Corporation to Participate in the 36th Annual ROTH Conference

13 Mar 2024 08:30:14 By Nasdaq GlobeNewswire

Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea

05 Jan 2024 08:30:12 By Nasdaq GlobeNewswire

Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million

02 Jan 2024 16:05:30 By Nasdaq GlobeNewswire